A First Time In Human Study To Assess The Compound GSK615915

NCT00400660 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchospasm

Interventions

DRUG: GSK615915A
DRUG: Placebo

Sponsor

GlaxoSmithKline